• vcard
D 314.622.6132
M 314-332-6696
  • Education
    • J.D., University of Missouri-Columbia School of Law, 1985
    • B.S., University of Missouri-Columbia, 1982, Chemical Engineering
  • Bar Jurisdictions
    • Illinois, 1990
    • Pennsylvania, 1985
    • District of Columbia (inactive)
    • Ohio (inactive)
    • Missouri, 2018
Andrew (Andy) Solomon utilizes his 30+ years of diversified experiences to provide clients in the pharmaceutical and chemical industries the opportunity to obtain an appropriate return on their investment. Andy has spent the majority of his career as an in-house practitioner, handling both intellectual property and commercial matters. He retired from the Perrigo Company, a leading global generic, store brand and value brand pharmaceutical company in 2017 and is a registered patent attorney with a chemical background. 

Andy’s practice focuses on:  
  • Comprehensive intellectual property, regulatory, and commercial strategies to enable the timely launch of pharmaceutical products
  • Intellectual property litigation and inter partes proceedings 
  • Intellectual property and regulatory counseling and portfolio development 
  • Commercial agreements 
  • Transactional due diligence 

Specific areas of focus include: 
  • Hatch Waxman intellectual property and regulatory issues 
  • Regulatory approval of pharmaceuticals 
  • Review of product labeling for regulatory compliance 
  • Acquisitions and divestitures of pharmaceutical and chemical companies 
  • Product development and supply agreements 
  • Generic, store brand and value brand marketing 
  • Formal client education
  • In house management of over fifty Hatch Waxman patent infringement lawsuits resulting in multiple trial and appeals court victories and favorable settlements.
  • Management of unfair competition litigation resulting in a jury verdict allowing the continued use of a comparison statement.
  • Participation as both lead commercial attorney and lead intellectual property attorney on multiple transactional matters having a positive fiscal impact on corporate earnings, including acquisitions, divestitures, and collaboration agreements.
  • Review of advertising, press releases and promotional materials for regulatory and legal compliance.
  • Drafting and issuing over 150 original patents across a diverse range of technologies including biochemical, chemical and mechanical. Prepare and register over 50 original trademarks and numerous copyrights. 
  • Conduct Intellectual Property Committee meetings where decisions regarding patent and trademark maintenance, application filing and global protection strategy are made.
  • Present seminars to clients on a wide array of topics including intellectual property, trade secrets and confidentiality, contracts, antitrust, compliance, advertising, regulatory law and document creation (paper and electronic).
eAlerts Alerts
August 2018
text icon Publications & Presentations
Co-Author, ACC Docket
October 2011
text icon Publications & Presentations
A Conversation between Brand Owners, Retailers and Manufacturers about Private Label in the United States
Presenter, INTA Annual Meeting
May 2011